ArticleJCO oncology practice2022

Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases Framework.

Florian R Schroeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.